BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30767829)

  • 1. Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.
    Kociolek LK; Kutty PK; Polgreen PM; Beekmann SE
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):276-280. PubMed ID: 30767829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
    Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic testing methods for Clostridium difficile infection: A statewide survey of Ohio acute care hospitals.
    Wong KK; Choi B; Fraser TG; Donskey CJ; Deshpande A
    Am J Infect Control; 2017 Mar; 45(3):306-307. PubMed ID: 28029400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
    Alnimr A; Alwazzeh MJ; Al-Ameer A
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K; Kopf D; Rösler A
    BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.
    Crobach MJT; Duszenko N; Terveer EM; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study.
    Christensen AB; Barr VO; Martin DW; Anderson MM; Gibson AK; Hoff BM; Sutton SH; Widmaier V; Salim AA; Silkaitis C; Qi C; Zembower TR; Postelnick MJ; Rhodes NJ
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):269-275. PubMed ID: 30786942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
    Parnell JM; Fazili I; Bloch SC; Lacy DB; Garcia-Lopez VA; Bernard R; Skaar EP; Edwards KM; Nicholson MR
    J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):378-383. PubMed ID: 32925555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship.
    Dbeibo L; Lucky CW; Fadel WF; Sadowski J; Beeler C; Kelley K; Williams J; Webb D; Kara A
    Clin Microbiol Infect; 2023 Jun; 29(6):798.e1-798.e4. PubMed ID: 36804907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
    Cook PP; Nichols S; Coogan M; Opera J; DeHart M
    Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Active Surveillance Testing for Clostridium difficile Colonization Using the cobas Cdiff Test.
    Patel PA; Schora DM; Singh K; Peterson LR
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367295
    [No Abstract]   [Full Text] [Related]  

  • 15. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential underreporting of treated patients using a
    Guh AY; Fridkin S; Goodenough D; Winston LG; Johnston H; Basiliere E; Olson D; Wilson CD; Watkins JJ; Korhonen L; Gerding DN
    Infect Control Hosp Epidemiol; 2024 May; 45(5):590-598. PubMed ID: 38268440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions.
    Kociolek LK; Patel SJ; Zheng X; Todd KM; Shulman ST; Gerding DN
    Pediatr Infect Dis J; 2016 Feb; 35(2):157-61. PubMed ID: 26517329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset
    McCormick WL; Jackson G; Andrea SB; Whitehead V; Chargualaf TL; Touzard-Romo F
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):106-109. PubMed ID: 37424227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls in Diagnosis of Pediatric Clostridium difficile Infection.
    Sammons JS; Toltzis P
    Infect Dis Clin North Am; 2015 Sep; 29(3):465-76. PubMed ID: 26188603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the Laboratory Diagnosis of Clostridium difficile Infection.
    Gilligan PH
    Clin Lab Med; 2015 Jun; 35(2):299-312. PubMed ID: 26004644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.